Sponsor
Emory University
Clinical research sponsor
How to interpret these research links
Connected source recordsThe exact organization name Emory University appears in 562 distinct published trial records. The links retain registry-reported sponsor and collaborator roles; differently spelled legal entities are not automatically merged. Recruiting status describes the current published registry snapshot, not an independently verified availability guarantee.
Data basis: current published ClinicalTrials.gov records and, where present, RxNorm, MONDO and FDA-label identifiers. See the evidence interpretation and counting methodology.
Advertisement
Clinical trials
60 shownAtezolizumab in Combination With Stereotactic Body Radiation Therapy (SBRT) and Surgery for Relapsed OsteosarcomaNCT06492954 · lead sponsor · 2026-10-01
RECRUITINGDiabetes Multimorbidity Typology, Trajectory, and Feasibility of an Audio Diary Mobile Application to Support Self-managementNCT07474376 · lead sponsor · 2026-09-01
RECRUITINGThrive With Type 1 Diabetes 2026NCT07522866 · lead sponsor · 2026-09-01
RECRUITINGANDREAS Registry (Assessment of Novel Drug-coated Balloon Revascularization: Effectiveness, Angiographic Outcomes, and Safety)NCT07559903 · lead sponsor · 2026-07-01
RECRUITINGInvestigating the Impact of GLP-1 RA Therapy on Osteosarcopenia in Older Female Adults With DiabetesNCT07428746 · lead sponsor · 2026-05-07
RECRUITINGZesty Exercise System for Therapeutic EngagementNCT07382674 · lead sponsor · 2026-03-16
RECRUITINGPersonalized Vaccine Immunotherapy in Combination With Checkpoint Inhibitor for Treatment of Triple Negative Breast CancerNCT06324240 · lead sponsor · 2025-12-02
RECRUITINGTesting the WeCare Intervention to Address Mental Health and Medication Adherence Challenges Among MSM in South AfricaNCT07226323 · lead sponsor · 2025-12-01
RECRUITINGAddressing Health Literacy With a Tailored Survivorship Care PlanNCT06674863 · lead sponsor · 2025-11-07
RECRUITINGHigh Dose Radiation Therapy With Pembrolizumab and Chemotherapy for the Treatment of Patients With PD-L1 Positive Metastatic Triple Negative Breast CancerNCT06492759 · lead sponsor · 2025-10-22
RECRUITINGComprehensive Assistance and Resources for Effective Diabetic Foot NavigationNCT07223268 · lead sponsor · 2025-10-07
RECRUITINGSisters for Heart Health: A Community Health Worker Initiative for Improving Heart Health in Farmworker WomenNCT07111026 · lead sponsor · 2025-09-16
RECRUITINGJAK Signaling in DepressionNCT07003997 · lead sponsor · 2025-09-03
RECRUITINGCARE-D-FOOT-Nav PilotNCT07143175 · lead sponsor · 2025-08-05
RECRUITINGLocomotion Adaptation Deficits in Older Adults With Mild Cognitive Impairment and Alzheimers DiseaseNCT06484244 · lead sponsor · 2025-07-22
RECRUITINGMobile Health Patient Navigation for the Improvement of Screening and the Early Detection of Breast Cancer in Women Accessing Primary Care Clinics in KenyaNCT07764796 · lead sponsor · 2025-07-22
RECRUITINGA Study Comparing Dexcom Continuous Glucose Monitoring to Point of Care Glucose Testing for the Management of Hospital and Post-Discharge Subjects With Type 1 DiabetesNCT06752928 · lead sponsor · 2025-05-12
RECRUITINGIncremental Vestibulo-ocular Reflex Adaptation as a Novel Treatment for Dizziness in People With Multiple SclerosisNCT06495138 · lead sponsor · 2025-04-21
RECRUITINGAn Investigational Scan (18F-rhPSMA-7.3 PET-mpMRI) for Targeted Prostate Biopsy Using TRUS-MR Fusion TechniqueNCT06865768 · lead sponsor · 2025-04-18
RECRUITINGDiclofenac for the Treatment of Patients With Metastatic Non-small Cell Lung Cancer on Single Agent ImmunotherapyNCT06731270 · lead sponsor · 2025-04-09
RECRUITINGEvaluating an Evidence-Based Family History Screening Program Adapted to Increase Reach and Uptake of Screening for BRCA-Associated Cancers in Rural Public Health ClinicsNCT06760507 · lead sponsor · 2025-02-01
RECRUITINGLeucine in Midlife DepressionNCT06580145 · lead sponsor · 2025-02-01
RECRUITINGREVELUTION-2: Relugolix+Abiraterone Acetate (AA) Versus Leuprolide+AA Cardiac TrialNCT06650579 · lead sponsor · 2025-01-31
RECRUITINGModeling Ketosis-Prone Diabetes Remission Via Diverse Mechanisms of GlucotoxicityNCT06699810 · lead sponsor · 2025-01-23
RECRUITINGBioenergetic Effect of Pioglitazone in CLD-PHNCT06336798 · lead sponsor · 2024-12-17
RECRUITINGProton Beam Radiation Therapy After Treatment for Resected N2 Non-Small Cell Lung CancerNCT06008730 · lead sponsor · 2024-12-13
RECRUITINGAcutherapy to Prevent Aromatase Inhibitor-Associated Arthralgias in Non-Hispanic Black Postmenopausal Women With Early-Stage Breast CancerNCT06534125 · lead sponsor · 2024-12-12
RECRUITINGCommunity, Home-based Education, Screening Services Strategy to Increase Cervical Cancer Control Access for HIV-Positive Women in NigeriaNCT06751030 · lead sponsor · 2024-12-03
RECRUITINGPropranolol and Pembrolizumab for Tumor Re-sensitization and Treatment of Patients With Checkpoint Inhibitor Refractory Metastatic or Unresectable Triple Negative Breast CancerNCT05741164 · lead sponsor · 2024-09-01
RECRUITINGDefactinib, Avutometinib and Nivolumab for the Treatment of Anti-PD1 Refractory LKB1-Mutant Advanced Non-Small Cell Lung CancerNCT06495125 · lead sponsor · 2024-07-31
RECRUITINGInspiring Seniors Towards Exercise Promotion to Protect CognitionNCT06496425 · lead sponsor · 2024-05-15
RECRUITINGAnti-Inflammatory Challenge in SchizophreniaNCT05823532 · lead sponsor · 2024-04-18
RECRUITINGHealth Behavior Intervention for Adults With Type 1 DiabetesNCT05823142 · lead sponsor · 2023-12-20
RECRUITINGInflammation and Depression in People With HIVNCT05849038 · lead sponsor · 2023-12-11
RECRUITINGFEED-Cystic Fibrosis (FEED-CF)NCT05766774 · lead sponsor · 2023-06-28
RECRUITINGEvaluating and Monitoring Immune and Clinical Responses in Early-Stage Triple Negative Breast Cancer Undergoing Neoadjuvant Chemo-immunotherapy With PembrolizumabNCT05877859 · lead sponsor · 2023-05-30
RECRUITINGLow Dose Naltrexone for Pain in Patients With HIVNCT05537935 · lead sponsor · 2023-04-28
RECRUITINGGlutamatergic Adaptation to Stress as a Mechanism for Anhedonia and Treatment Response With KetamineNCT05327699 · lead sponsor · 2022-11-08
RECRUITINGLow-Dose Interleukin-2 and Pembrolizumab for the Treatment of Stage IV Non-Small Cell Lung CancerNCT05493566 · lead sponsor · 2022-11-01
RECRUITINGLetrozole With and Without Simvastatin for the Treatment of Stage I-III Hormone Receptor Positive, HER2 Negative Breast CancerNCT05464810 · lead sponsor · 2022-09-02
RECRUITINGPalliative Radiotherapy With Lurbinectedin in Patients With Extensive Stage Small Cell Lung CancerNCT05244239 · lead sponsor · 2022-07-27
RECRUITINGMoving Yourself in Space and Time: MYSTICNCT07697664 · lead sponsor · 2022-03-25
RECRUITINGCortical Electrophysiology of Response Inhibition in Parkinson's DiseaseNCT06234995 · lead sponsor · 2021-08-09
RECRUITINGMRX-2843 and Osimertinib for the Treatment of Advanced EGFR Mutant Non-small Cell Lung CancerNCT04762199 · lead sponsor · 2021-02-24
RECRUITINGProton Radiation Therapy for the Treatment of Patients With High Risk Prostate CancerNCT04725903 · lead sponsor · 2021-02-01
RECRUITINGProspective Study of Intensity-Modulated Proton Therapy (IMPT) for Small Cell Lung CancerNCT04342429 · lead sponsor · 2020-03-19
RECRUITINGNeurovascular Transduction During Exercise in Chronic Kidney DiseaseNCT02947750 · lead sponsor · 2016-10-01
RECRUITINGImproving Health Literacy in African-American Prostate Cancer PatientsNCT03322891 · lead sponsor · 2016-07-21
RECRUITINGIntegrating Supports to Promote PrEP for Black Adolescents Working With Apps- AtlantaNCT07535346 · lead sponsor · 2027-04-01
NOT_YET_RECRUITINGImproving TelePrEP Initiation and Retention Outcomes in the US: The MISTR+ StudyNCT07821671 · lead sponsor · 2027-03-01
NOT_YET_RECRUITINGProject SPACE: Testing Daily Text Messages to Reduce Alcohol Use and HIV Risk BehaviorNCT07769580 · lead sponsor · 2027-02-01
NOT_YET_RECRUITINGEnhancing Cervical Cancer Screening and Treatment in Women Living With HIV in Kenya, the ENHANCE LINKAge TrialNCT06708351 · lead sponsor · 2026-12-31
NOT_YET_RECRUITINGUse of ACU-D1 in HPV Associated Vulvar and Perianal Lesions in People With HIVNCT06233331 · lead sponsor · 2026-12-01
NOT_YET_RECRUITINGPluvicto for the Treatment of African American Men With Metastatic Castration-Resistant Prostate CancerNCT07860554 · lead sponsor · 2026-11-02
NOT_YET_RECRUITINGA Randomized Pragmatic Study of CT- Versus MRI-Based Planning for High-Dose-Rate Prostate Brachytherapy for Prostate CancerNCT07859722 · lead sponsor · 2026-11-02
NOT_YET_RECRUITINGIntegrating Supports to Promote PrEP for Black Adolescents Working With Apps- AlabamaNCT06876324 · lead sponsor · 2026-11-01
NOT_YET_RECRUITINGCGM Use in Heart FailureNCT07045298 · lead sponsor · 2026-11-01
NOT_YET_RECRUITINGBaricitinib Curative Repression of HIV-1NCT07209267 · lead sponsor · 2026-10-01
NOT_YET_RECRUITINGAdaptango Performance PRocess for Older Adults Community reHabilitationNCT07824128 · lead sponsor · 2026-10-01
NOT_YET_RECRUITINGDiabetes Prevention AI: Enhancing Prevention Strategies Using Personalized Nutrition and Fitness Coaching for the Next GenerationNCT07824154 · lead sponsor · 2026-10-01
NOT_YET_RECRUITINGDrugs studied in this sponsor's trials
120 mapped RxNorm conceptsThese drug records are connected through ClinicalTrials.gov studies listing Emory University as a sponsor, collaborator or responsible party. Each count is the number of distinct trials containing the mapped drug intervention. This does not establish that the organization manufactures, owns, sells or developed the drug.
docetaxel6
carboplatin5
escitalopram5
paclitaxel5
everolimus4
insulin glargine4
sitagliptin4
cyclophosphamide3
docetaxel RxCUI 72962 · Lead sponsor in 6 linked trial(s) · 0 currently recruiting
6 trials
carboplatin RxCUI 40048 · Lead sponsor in 5 linked trial(s) · 1 currently recruiting
5 trials
escitalopram RxCUI 321988 · Lead sponsor in 5 linked trial(s) · 0 currently recruiting
5 trials
paclitaxel RxCUI 56946 · Lead sponsor in 5 linked trial(s) · 1 currently recruiting
5 trials
everolimus RxCUI 141704 · Lead sponsor in 4 linked trial(s) · 0 currently recruiting
4 trials
insulin glargine RxCUI 274783 · Lead sponsor in 4 linked trial(s) · 0 currently recruiting
4 trials
sitagliptin RxCUI 593411 · Lead sponsor in 4 linked trial(s) · 0 currently recruiting
4 trials
cyclophosphamide RxCUI 3002 · Lead sponsor in 3 linked trial(s) · 0 currently recruiting
3 trials
letrozole RxCUI 72965 · Lead sponsor in 3 linked trial(s) · 1 currently recruiting
3 trials
palbociclib RxCUI 1601374 · Lead sponsor in 3 linked trial(s) · 0 currently recruiting
3 trials
Truvada RxCUI 495430 · Lead sponsor in 3 linked trial(s) · 0 currently recruiting
3 trials
anastrozole RxCUI 84857 · Lead sponsor in 2 linked trial(s) · 0 currently recruiting
2 trials
atezolizumab RxCUI 1792776 · Lead sponsor in 1 linked trial(s) · 1 currently recruiting
2 trials
baricitinib RxCUI 2047232 · Lead sponsor in 2 linked trial(s) · 2 currently recruiting
2 trials
Biktarvy RxCUI 1999668 · Lead sponsor in 2 linked trial(s) · 0 currently recruiting
2 trials
calcitriol RxCUI 1894 · Lead sponsor in 0 linked trial(s) · 0 currently recruiting
2 trials
candesartan RxCUI 214354 · Lead sponsor in 2 linked trial(s) · 0 currently recruiting
2 trials
cisplatin RxCUI 2555 · Lead sponsor in 2 linked trial(s) · 0 currently recruiting
2 trials
dexamethasone RxCUI 3264 · Lead sponsor in 2 linked trial(s) · 0 currently recruiting
2 trials
doxorubicin RxCUI 3639 · Lead sponsor in 2 linked trial(s) · 0 currently recruiting
2 trials
doxycycline RxCUI 3640 · Lead sponsor in 2 linked trial(s) · 0 currently recruiting
2 trials
emtricitabine / tenofovir disoproxil Oral Tablet RxCUI 540395 · Lead sponsor in 0 linked trial(s) · 0 currently recruiting
2 trials
exemestane RxCUI 258494 · Lead sponsor in 2 linked trial(s) · 0 currently recruiting
2 trials
fluoxetine RxCUI 4493 · Lead sponsor in 2 linked trial(s) · 0 currently recruiting
2 trials
Sponsor roles
lead sponsor427
collaborator135
Advertisement
Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.